SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ilv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9A_A_BEZA306_0 (CHLOROCATECHOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	7 / 11	GLY A 85 PRO A 86 TYR A 138 TYR A 167 ARG A 170 HIS A 173 HIS A 175	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) FE A 301 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A)	0.43A	1s9aA-4ilvA: 19.9	1s9aA-4ilvA: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9A_B_BEZB307_0 (CHLOROCATECHOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	8 / 12	GLY A 85 PRO A 86 TYR A 138 TYR A 167 ARG A 170 HIS A 173 HIS A 175 GLN A 189	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) FE A 301 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A) EDO A 302 ( 4.4A)	0.44A	1s9aB-4ilvA: 22.2	1s9aB-4ilvA: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9A_B_BEZB307_0 (CHLOROCATECHOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	5 / 12	GLY A 85 PRO A 86 TYR A 167 HIS A 173 GLN A 189	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) FE A 301 ( 4.5A) FE A 301 ( 3.3A) EDO A 302 ( 4.4A)	1.36A	1s9aB-4ilvA: 22.2	1s9aB-4ilvA: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TMX_A_BEZA881_0 (HYDROXYQUINOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	7 / 11	GLY A 85 PRO A 86 TYR A 138 TYR A 167 ARG A 170 HIS A 173 HIS A 175	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) FE A 301 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A)	0.36A	1tmxA-4ilvA: 19.0	1tmxA-4ilvA: 23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TMX_B_BEZB882_0 (HYDROXYQUINOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	7 / 12	GLY A 85 PRO A 86 TYR A 138 TYR A 167 ARG A 170 HIS A 173 HIS A 175	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) FE A 301 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A)	0.37A	1tmxB-4ilvA: 20.0	1tmxB-4ilvA: 23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TMX_B_BEZB882_0 (HYDROXYQUINOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	5 / 12	GLY A 85 TYR A 167 ARG A 170 HIS A 173 HIS A 175	EDO A 302 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A)	1.36A	1tmxB-4ilvA: 20.0	1tmxB-4ilvA: 23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HGI_A_BEZA284_0 (CATECHOL 1,2-DIOXYGENASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	8 / 12	GLY A 85 PRO A 86 TYR A 87 TYR A 138 TYR A 167 ARG A 170 HIS A 173 HIS A 175	EDO A 302 ( 4.2A) EDO A 302 (-4.4A) EDO A 302 (-4.3A) FE A 301 ( 4.2A) FE A 301 ( 4.5A) EDO A 302 (-3.8A) FE A 301 ( 3.3A) FE A 301 ( 3.4A)	0.49A	3hgiA-4ilvA: 21.0	3hgiA-4ilvA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESK_A_1YNA701_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	4 / 4	ALA A 137 PRO A 86 LEU A 203 HIS A 173	None EDO A 302 (-4.4A) None FE A 301 ( 3.3A)	1.14A	5eskA-4ilvA: undetectable	5eskA-4ilvA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	4ilv	INTRADIOL RING-CLEAVAGE DIOXYGENASE (Streptomyces sp. SirexAA-E)	5 / 11	LEU A 159 GLY A 221 SER A 97 LEU A 98 ARG A 172	None	0.88A	5o96G-4ilvA: undetectable	5o96G-4ilvA: 21.64

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1S9A_A_BEZA306_0","CHLOROCATECHOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",7,"GLY A  85;PRO A  86;TYR A 138;TYR A 167;ARG A 170;HIS A 173;HIS A 175","EDO A 302 ( 4.2A);EDO A 302 (-4.4A); FE A 301 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A)","0.43A","1s9aA-4ilvA:19.9","1s9aA-4ilvA:25.76"],["1S9A_B_BEZB307_0","CHLOROCATECHOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",8,"GLY A  85;PRO A  86;TYR A 138;TYR A 167;ARG A 170;HIS A 173;HIS A 175;GLN A 189","EDO A 302 ( 4.2A);EDO A 302 (-4.4A); FE A 301 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A);EDO A 302 ( 4.4A)","0.44A","1s9aB-4ilvA:22.2","1s9aB-4ilvA:25.76"],["1S9A_B_BEZB307_0","CHLOROCATECHOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",5,"GLY A  85;PRO A  86;TYR A 167;HIS A 173;GLN A 189","EDO A 302 ( 4.2A);EDO A 302 (-4.4A); FE A 301 ( 4.5A); FE A 301 ( 3.3A);EDO A 302 ( 4.4A)","1.36A","1s9aB-4ilvA:22.2","1s9aB-4ilvA:25.76"],["1TMX_A_BEZA881_0","HYDROXYQUINOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",7,"GLY A  85;PRO A  86;TYR A 138;TYR A 167;ARG A 170;HIS A 173;HIS A 175","EDO A 302 ( 4.2A);EDO A 302 (-4.4A); FE A 301 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A)","0.36A","1tmxA-4ilvA:19.0","1tmxA-4ilvA:23.05"],["1TMX_B_BEZB882_0","HYDROXYQUINOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",7,"GLY A  85;PRO A  86;TYR A 138;TYR A 167;ARG A 170;HIS A 173;HIS A 175","EDO A 302 ( 4.2A);EDO A 302 (-4.4A); FE A 301 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A)","0.37A","1tmxB-4ilvA:20.0","1tmxB-4ilvA:23.05"],["1TMX_B_BEZB882_0","HYDROXYQUINOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",5,"GLY A  85;TYR A 167;ARG A 170;HIS A 173;HIS A 175","EDO A 302 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A)","1.36A","1tmxB-4ilvA:20.0","1tmxB-4ilvA:23.05"],["3HGI_A_BEZA284_0","CATECHOL 1,2-DIOXYGENASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",8,"GLY A  85;PRO A  86;TYR A  87;TYR A 138;TYR A 167;ARG A 170;HIS A 173;HIS A 175","EDO A 302 ( 4.2A);EDO A 302 (-4.4A);EDO A 302 (-4.3A); FE A 301 ( 4.2A); FE A 301 ( 4.5A);EDO A 302 (-3.8A); FE A 301 ( 3.3A); FE A 301 ( 3.4A)","0.49A","3hgiA-4ilvA:21.0","3hgiA-4ilvA:23.44"],["5ESK_A_1YNA701_2","LANOSTEROL 14-ALPHA DEMETHYLASE","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",4,"ALA A 137;PRO A  86;LEU A 203;HIS A 173","None;EDO A 302 (-4.4A);None; FE A 301 ( 3.3A)","1.14A","5eskA-4ilvA:undetectable","5eskA-4ilvA:18.76"],["5O96_G_SAMG501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","4ilv","INTRADIOL RING-CLEAVAGE DIOXYGENASE","Streptomyces sp. SirexAA-E",5,"LEU A 159;GLY A 221;SER A  97;LEU A  98;ARG A 172","None","0.88A","5o96G-4ilvA:undetectable","5o96G-4ilvA:21.64"]]